Pegylated interferon alfa 2b (PEG-IFN) and ribavirin for hepatitis C patients who were nonresponders to previous therapy

被引：0
|
作者：
Lawitz, EJ
Cantu, NS
Becker, S
Dhar, R
Li, J
Bala, NS
Gordon, S
Davis, M
Nader, P
Holtzmuller, K
Rosenfield, T
Monsour, H
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
80
引用
收藏
页码：A626 / A626
页数：1
相关论文
共 50 条
  • [41] Peg-IFN alfa-2a plus ribavirin is superior compared to high dose consensus interferon (CIFN) and ribavirin in the treatment of patients with chronic hepatitis C
    Witthoeft, Thomas
    HEPATOLOGY, 2007, 46 (04) : 390A - 390A
  • [42] Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C
    Sulkowski, Mark S.
    Cooper, Curtis
    Hunyady, Bela
    Jia, Jidong
    Ogurtsov, Pavel
    Peck-Radosavljevic, Markus
    Shiffman, Mitchell L.
    Yurdaydin, Cihan
    Dalgard, Olav
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (04) : 212 - 223
  • [43] Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C
    Mark S. Sulkowski
    Curtis Cooper
    Bela Hunyady
    Jidong Jia
    Pavel Ogurtsov
    Markus Peck-Radosavljevic
    Mitchell L. Shiffman
    Cihan Yurdaydin
    Olav Dalgard
    Nature Reviews Gastroenterology & Hepatology, 2011, 8 : 212 - 223
  • [44] Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C
    Zobair M. Younossi
    Arthur C. McCullough
    David S. Barnes
    Anthony Post
    Janus P. Ong
    Robert O’shea
    Lisa M. Martin
    Diane Bringman
    Denise Farmer
    Gavin Levinthal
    Kevin D. Mullen
    William D. Carey
    Anthony S. Tavill
    Roy Ferguson
    Terry Gramlich
    Digestive Diseases and Sciences, 2005, 50 : 970 - 975
  • [45] Pegylated interferon α-2b, ribavirin and amantadine for chronic hepatitis C
    Younossi, ZM
    McCullough, A
    Barnes, D
    Post, A
    Ong, J
    O'Shea, R
    Martin, LM
    Bringman, D
    Farmer, D
    Levinthal, G
    Mullen, KD
    Carey, WD
    Tavill, AS
    Ferguson, R
    Gramlich, T
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (05) : 970 - 975
  • [46] ASSOCIATION OF ITPA SNP WITH THE GENE EXPRESSION PROFILE OF CHRONIC HEPATITIS C (CH-C) PATIENTS WHO DEVELOP ANEMIA DURING TREATMENT WITH PEGYLATED INTERFERON ALFA AND RIBAVIRIN (PEG-IFN/RBV)
    Estep, J. Michael
    Birerdinc, Aybike
    Afendy, Arian
    Stepanova, Maria
    Baranova, Ancha
    Younossi, Zobair M.
    HEPATOLOGY, 2011, 54 : 1177A - 1177A
  • [47] Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    Kainuma, Mosaburo
    Furusyo, Norihiro
    Kajiwara, Eiji
    Takahashi, Kazuhiro
    Nomura, Hideyuki
    Tanabe, Yuichi
    Satoh, Takeaki
    Maruyama, Toshihiro
    Nakamuta, Makoto
    Kotoh, Kazuhiro
    Azuma, Koichi
    Shimono, Junya
    Shimoda, Shinji
    Hayashi, Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (35) : 4400 - 4409
  • [48] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers.
    Jacobson, I
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Rovner, D
    Brass, C
    HEPATOLOGY, 2002, 36 (04) : 358A - 358A
  • [49] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers.
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Pizov, O
    Brass, C
    HEPATOLOGY, 2001, 34 (04) : 338A - 338A
  • [50] Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    Mosaburo Kainuma
    Norihiro Furusyo
    Eiji Kajiwara
    Kazuhiro Takahashi
    Hideyuki Nomura
    Yuichi Tanabe
    Takeaki Satoh
    Toshihiro Maruyama
    Makoto Nakamuta
    Kazuhiro Kotoh
    Koichi Azuma
    Junya Shimono
    Shinji Shimoda
    Jun Hayashi
    World Journal of Gastroenterology, 2010, 16 (35) : 4400 - 4409
12345